DOSSIER · 13F Holders · Q2 2026
DCOY

DECOY THERAPEUTICS INC

5 institutions still hold DECOY THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 79400X602·5 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$31K
visible holders
Holders
5
filers reporting
Concentration
92.79%
VANGUARD CAPITAL MANAGEMENT LLC #1
top holder share
AI Holders Summary · Q2 2026

5 institutions reported DCOY in Q2 2026. VANGUARD CAPITAL MANAGEMENT LLC leads at 92.8% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$29K4K0.00%Q2 2026
02
Tower Research Capital LLC (TRC)
CIK 0001533421
$2K2560.00%Q2 2026
03
SBI Securities Co., Ltd.
CIK 0001851815
$2191110.00%Q3 2026
04
UBS Group AG
CIK 0001610520
$180250.00%Q2 2026
05
Caitong International Asset Management Co., Ltd
CIK 0001963355
$1420.00%Q2 2026
Insiders at DECOY THERAPEUTICS INC
Lieber Jonathan I →Mcvicar William K. →Burleson Tess →Lammers Paul →Hanish Arnold C →Hibner Barbara Louise →Rosenblum Mark J →Marschel Peter Klaus →